Cargando…

Improved Hepatic Reserve and Fibrosis in a Case of “Portal-Systemic Liver Failure” by Portosystemic Shunt Occlusion

Patient: Female, 67-year-old Final Diagnosis: Portal-systemic liver failure Symptoms: None (second opinion) Medication: None Clinical Procedure: Balloon-occluded retrograde transvenous obliteration (BRTO) Specialty: Radiology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: This is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishikawa, Tsuyoshi, Sasaki, Ryo, Nishimura, Tatsuro, Iwamoto, Takuya, Takami, Taro, Yamasaki, Takahiro, Sakaida, Isao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038637/ https://www.ncbi.nlm.nih.gov/pubmed/32063601 http://dx.doi.org/10.12659/AJCR.921236

Ejemplares similares

A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification
por: Ishikawa, Tsuyoshi, et al.
Publicado: (2019)

Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification
por: Ishikawa, Tsuyoshi, et al.
Publicado: (2020)

Trans-portal hepatic infusion of cultured bone marrow-derived mesenchymal stem cells in a steatohepatitis murine model
por: Sasaki, Ryo, et al.
Publicado: (2020)

Novel Therapeutic Strategy Using Interventional Radiology (IVR) for Hepatitis C Virus (HCV)-Related Decompensated Liver Cirrhosis: A Case Report
por: Iwamoto, Takuya, et al.
Publicado: (2019)

Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: A comparison with sorafenib therapy
por: Saeki, Issei, et al.
Publicado: (2019)

Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
por: Huang, Long, et al.
Publicado: (2015)

A New Therapeutic Assessment Score for Advanced Hepatocellular Carcinoma Patients Receiving Hepatic Arterial Infusion Chemotherapy
por: Saeki, Issei, et al.
Publicado: (2015)

Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
por: Saeki, Issei, et al.
Publicado: (2016)

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
por: Tripathi, Dhiraj, et al.
Publicado: (2020)

Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
por: Luo, Xuefeng, et al.
Publicado: (2014)

Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy
por: Saeki, Issei, et al.
Publicado: (2018)

Drastic Improvement in Hepatitis B/C Virus-induced Decompensated Liver Cirrhosis Treated by Total Management Consisting of Interventional Radiology, Endoscopy, and Pharmacotherapy
por: Nishimura, Tatsuro, et al.
Publicado: (2022)

Combination with portosystemic shunt occlusion and antiviral therapy improves prognosis of decompensated cirrhosis
por: Tamai, Hideyuki, et al.
Publicado: (2020)

The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status
por: Pomier-Layrargues, Gilles, et al.
Publicado: (2012)

Asymptomatic presentation of a congenital malformation of the portal vein with portosystemic shunt
por: Musa, Juna, et al.
Publicado: (2020)

Vasoactive intestinal peptide in canine portosystemic shunt in the absence of portal hypertension
por: Isaka, Mitsuhiro, et al.
Publicado: (2021)

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis
por: Iwamoto, Takuya, et al.
Publicado: (2016)

A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow–derived cells
por: Matsuda, Takashi, et al.
Publicado: (2017)

Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model
por: Nishimura, Tatsuro, et al.
Publicado: (2019)

Congenital portosystemic shunt occlusion with an Amplatzer PFO occlusion device: a case report
por: Shnayder, Michelle M., et al.
Publicado: (2021)

Intractable Hepatic Encephalopathy with a Large Portosystemic Shunt Successfully Treated Using Shunt-preserving Disconnection of the Portal and Systemic Circulation
por: Haraguchi, Masafumi, et al.
Publicado: (2020)

Transjugular intrahepatic portosystemic shunt via left hepatic – left portal veins
por: Maleux, Geert
Publicado: (2019)

The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
por: Lee, Hae Lim, et al.
Publicado: (2022)

Advanced portal venous access techniques for transjugular intrahepatic portosystemic shunt placement
por: Partovi, Sasan, et al.
Publicado: (2021)

Acquired Portosystemic Shunts in Cirrhosis and Portal Vein Thrombosis: A Case Report
por: Durgham, Anthony, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt for pediatric portal hypertension: A meta-analysis
por: Raissi, Driss, et al.
Publicado: (2023)

Hepatic encephalopathy due to extrahepatic portosystemic shunt
por: Sazumi, Yosuke, et al.
Publicado: (2020)

Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein
por: Wang, Lei, et al.
Publicado: (2017)

Transsplenic portal vein reconstruction–transjugular intrahepatic portosystemic shunt in a patient with portal and splenic vein thrombosis
por: Salsamendi, Jason T., et al.
Publicado: (2016)

Application of transmesenteric vein extrahepatic portosystemic shunt in treatment of symptomatic portal hypertension with cavernous transformation of portal vein
por: Li, Weixiao, et al.
Publicado: (2023)

Transjugular Intrahepatic Portosystemic Shunt for Maintenance of Portal Venous Patency in Liver Transplant Candidates
por: Gaba, Ron Charles, et al.
Publicado: (2013)

Multiple acquired portosystemic shunts secondary to primary hypoplasia of the portal vein in a cat
por: SUGIMOTO, Satoko, et al.
Publicado: (2018)

Transjugular Intrahepatic Portosystemic Shunt as the Treatment for Refractory Hepatic Hydrothorax with Portal Vein Thrombosis
por: Zhang, Lin-Hao, et al.
Publicado: (2017)

Congenital portosystemic venous shunt
por: Papamichail, M., et al.
Publicado: (2017)

An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells
por: Fujisawa, Koichi, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertensive biliopathy with cavernous transformation of the portal vein: a case report
por: Zhao, Ming, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension
por: Yan, Xuan-Hui, et al.
Publicado: (2022)

Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus
por: Zhang, Yue, et al.
Publicado: (2019)

Transsplenic portal vein recanalization and direct intrahepatic portosystemic shunt placement to optimize liver transplantation
por: Ahmed, Osman, et al.
Publicado: (2020)

Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature
por: Qi, Xingshun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dpsm84losc8e3l0pdlbrtg1m68